FR227244, a Novel Antifungal Antibiotic from Myrothecium cinctum No. 002 : II. Biological Properties and Model of Action
スポンサーリンク
概要
- 論文の詳細を見る
- 2004-12-25
著者
-
Sato I
Fermentation Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Sato Ikuko
藤沢薬品工業
-
Sato Ikuko
Fermentation Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Fujie Akihiko
Fermentation Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
HASHIMOTO Michizane
Fermentation Research Laboratories, Drug Discovery Research, Astellas Pharma Inc.
-
KOBAYASHI Motoo
Fermentation Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
HINO Motohiro
Fermentation Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
HORI Yasuhiro
Fermentation Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
ABE Fumie
Fermentation Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
NITTA Kumiko
Fermentation Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
Hashimoto Michizane
Fermentation Research Laboratories Drug Discovery Research Astellas Pharma Inc.
-
Hashimoto Michizane
Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Abe Fumie
Fermentation Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Nitta Kumiko
Fermentation Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Hino Motohiro
Fermentation Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Fujie Akihiko
Fermentation Research Laboratories Astellas Pharma Inc.
-
Hori Yasuhiro
Fermentation Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Kobayashi Motoo
Fermentation Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Fujie Akihiko
Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Hino Motohiro
Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Hino Motohiro
Fermentation Research Laboratories Drug Discovery Research Astellas Pharma Inc.
-
Hino Motohiro
Fermentation And Biotechnology Laboratories Astellas Pharma Inc.
-
Hashimoto Michizane
Fermentation And Biotechnology Laboratories
関連論文
- The Novel Gluconeogenesis Inhibitors FR225659 and Related Compounds that Originate from Helicomyces sp. No. 19353 : II. Biological Profiles
- Naphthalecin, a Novel Antibiotic Produced by the Anaerobic Bacterium, Sporotalea colonica sp. nov.
- FR901512, a Novel HMG-CoA Reductase Inhibitor Produced by an Agonomycetous Fungus No. 14919 : II. Biological Profiles
- FR901512, a Novel HMG-CoA Reductase Inhibitor Produced by an Agonomycetous Fungus No. 14919 : I. Taxonomy of the Producing Organism, Fermentation, Islation and Physico-chemical Properties
- FR171456, a Novel Cholesterol Synthesis Inhibitor Produced by Sporormiella minima No. 15604 : II. Biological Activities
- FR171456, a Novel Cholesterol Synthesis Inhibitor Produced by Sporormiella minima No. 15604 : I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties
- The Novel Gluconeogenesis Inhibitors FR225659 and Related Compounds that Originate from Helicomyces sp. No.19353 : I. Taxonomy, Fermentation, Isolation and Physico-chemical Properties
- FR235222, a Fungal Metabolite, is a Novel Immunosuppressant that Inhibits Mammalian Histone Deacetylase (HDAC) II. Biological Activities in Animal Models
- FR252921, a Novel Immunosuppressive Agent Isolated from Pseudomonas fluorescens No.408813 III. In Vivo Activities
- FR235222, a Fungal Metabolite, is a Novel Immunosuppressant that Inhibits Mammalian Histone Deacetylase (HDAC) I. Taxonomy, Fermentation, Isolation and Biological Activities